270 related articles for article (PubMed ID: 37356012)
41. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
43. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis.
Brodsky RA; Hu R
Leuk Lymphoma; 2006 Jul; 47(7):1215-21. PubMed ID: 16923549
[TBL] [Abstract][Full Text] [Related]
44. [Paroxysmal nocturnal hemoglobinuria and aplastic anemia].
Thollot F; Bordigoni P; Olive D
Arch Fr Pediatr; 1984 Mar; 41(3):197-200. PubMed ID: 6742973
[TBL] [Abstract][Full Text] [Related]
45. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
[TBL] [Abstract][Full Text] [Related]
46. Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
Oved JH; Stanley N; Babushok DV; Huang Y; Duke JL; Monos DS; Teachey DT; Olson TS
Pediatr Transplant; 2019 Jun; 23(4):e13393. PubMed ID: 30900367
[TBL] [Abstract][Full Text] [Related]
47. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
48. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
Passweg JR
Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
[TBL] [Abstract][Full Text] [Related]
49. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Okamoto M; Ikeda K; Kaneshige T; Sugiyama H; Terasawa T; Osumi K; Maruyama Y
Blood; 2002 Jul; 100(1):22-8. PubMed ID: 12070003
[TBL] [Abstract][Full Text] [Related]
50. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Kinoshita T; Inoue N
Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
[TBL] [Abstract][Full Text] [Related]
51. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia.
Hugel B; Socié G; Vu T; Toti F; Gluckman E; Freyssinet JM; Scrobohaci ML
Blood; 1999 May; 93(10):3451-6. PubMed ID: 10233897
[TBL] [Abstract][Full Text] [Related]
52. The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
Shah YB; Priore SF; Li Y; Tang CN; Nicholas P; Kurre P; Olson TS; Babushok DV
Blood Adv; 2021 Aug; 5(16):3216-3226. PubMed ID: 34427585
[TBL] [Abstract][Full Text] [Related]
53. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
[TBL] [Abstract][Full Text] [Related]
54. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
55. Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
Narita A; Muramatsu H; Okuno Y; Sekiya Y; Suzuki K; Hamada M; Kataoka S; Ichikawa D; Taniguchi R; Murakami N; Kojima D; Nishikawa E; Kawashima N; Nishio N; Hama A; Takahashi Y; Kojima S
Br J Haematol; 2017 Sep; 178(6):954-958. PubMed ID: 28643364
[TBL] [Abstract][Full Text] [Related]
56. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
57. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
58. Advances in understanding the pathogenesis of acquired aplastic anaemia.
Luzzatto L; Risitano AM
Br J Haematol; 2018 Sep; 182(6):758-776. PubMed ID: 29974931
[TBL] [Abstract][Full Text] [Related]
59. Clonal evolution in aplastic anemia.
Afable MG; Tiu RV; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2011; 2011():90-5. PubMed ID: 22160018
[TBL] [Abstract][Full Text] [Related]
60. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
